CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.

However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock soaring Wednesday.

Cantor Fitzgerald upgraded CVS Health (NYSE:CVS) to Overweight from Neutral and increased its 12-month per-share target to $71 from $62 on Wednesday after the managed care giant delivered ...

CVS Health CVS turned in solid fourth-quarter results, and its 2025 guidance for 6%-11% adjusted EPS growth without any share ...